Chavarro JE, Toth TL, Wright DL, Meeker JD, Hauser R
Melanocortin-4 receptor in the medial amygdala regulates emotional stress-induced anxiety-like behavior, anorexia and corticosterone secretion
Its label was updated to add potential interactions with radiation therapies
Modern glucose-lowering therapies, particularly glucagon-like peptide-1 receptor agonists (GLP-1 RAs), align well with this approach owing to their benefits in glycemic control, weight loss, and reduced cardiovascular and kidney risks [12,13,14,15]
Products ship in lyophilized (freeze-dried) form and require proper reconstitution before use in research settings